Hansoh Pharmaceutical Group Co (HKSE:03692) Sale Of Property, Plant, Equipment : HK$12 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Sale Of Property, Plant, Equipment?

Hansoh Pharmaceutical Group Co's sale of property, plant, equipment for the six months ended in Dec. 2023 was HK$9 Mil. It means Hansoh Pharmaceutical Group Co gained HK$9 Mil from selling property, plant, and equipment. Hansoh Pharmaceutical Group Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was HK$12 Mil.

Compared with last quarter (HK$3 Mil in Jun. 2023 ), Hansoh Pharmaceutical Group Co gained more money from selling property, plant, and equipment in Dec. 2023 (HK$9 Mil).

Hansoh Pharmaceutical Group Co Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Sale Of Property, Plant, Equipment Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

12.29

9.57

67.07

23.56

11.99

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial									62.32	4.16	19.60	2.60	9.39

Hansoh Pharmaceutical Group Co Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$12 Mil.

Hansoh Pharmaceutical Group Co Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Sale Of Property, Plant, Equipment

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Executives

Cen Junda	2307 Founder of a discretionary trust who can infl
Cantrust (far East) Limited	2301 Trustee
Jqc Holding Limited	2201 Interest of corporation controlled by you
Jqc International Limited	2201 Interest of corporation controlled by you
Sun Yuan	2101 Beneficial owner
Harmonia Holding Investing (ptc) Limited	2201 Interest of corporation controlled by you
Stellar Infinity Company Ltd.	2101 Beneficial owner
Sunrise Investment Advisors Limited	2201 Interest of corporation controlled by you
Zhong Huijuan	2307 Founder of a discretionary trust who can infl
Apex Medical Company Ltd.	2101 Beneficial owner

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines